| NCT ID | Title | Condition | Status |
|---|---|---|---|
| Phase 4 | |||
| NCT06118905 | Preserving Geriatric Muscle With an Osteoporosis Medication | Osteoporosis | Recruiting |
| NCT03921060 | Markers of Osteoporosis in Cystic Fibrosis | Cystic Fibrosis | Recruiting |
| NCT05666310 | Muscle Impact of Treating Osteoporosis | Sarcopenia | Active, Not Recruiting |
| NCT05010590 | Anabolic Therapy in Postmenopausal Osteoporosis | Postmenopausal Osteoporosis | Active, Not Recruiting |
| Phase 3 | |||
| NCT02051218 | Prevention of Symptomatic Skeletal Events With Denosumab Administered Every 4 Weeks… | Metastatic Breast Cancer | Active, Not Recruiting |
| Phase 2 | |||
| NCT04608630 | Bone Loss Prevention With Zoledronic Acid or Denosumab in Critically Ill Adults | Critical Illness | Recruiting |
| NCT04800367 | Romosozumab/Denosumab Study for Premenopausal IOP | Premenopausal Idiopathic Osteoporosis | Active, Not Recruiting |
| NCT04067726 | RANKL Inhibition and Mammographic Breast Density | Dense Breasts | Active, Not Recruiting |
| NCT07537972 | Denosumab Strategy for Liver Cancer With Bone Metastases | Hepatocellular Carcinoma (HCC) | Not Yet Recruiting |
| NCT04232657 | Romosozumab to Improve Bone Mineral Density and Architecture in Chronic SCI | Spinal Cord Injury (=3 Years) | Active, Not Recruiting |
| Phase 1/2 | |||
| NCT06374459 | Zunsemetinib in Combination With Capecitabine in Patients With Hormone Receptor-Positive… | Hormone Receptor Positive HER-2 Negative Metastatic Breast Cancer | Recruiting |
| NCT06706414 | NT-NOA - Novel Treatment of Some Men With Non-Obstructive Azoospermia | Infertility, Male | Active, Not Recruiting |
| Not specified | |||
| NCT05866029 | Study of the Key Techniques of Prevention and Treatment of Osteoporotic Refracture | Osteoporotic Fractures | Recruiting |
| NCT03958565 | Response of Bony Metastasis to Tyrosine Kinase Inhibitors in Non-Small Cell Lung Cancers… | Carcinoma, Non-Small-Cell Lung | Recruiting |